Calquence

List of products in the National Drug Code with proprietary name calquence. This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0310-0512Calquence AcalabrutinibCapsule, Gelatin CoatedOralAstrazeneca Pharmaceuticals LpHuman Prescription Drug
0310-3512Calquence AcalabrutinibTablet, Film CoatedOralAstrazeneca Pharmaceuticals LpHuman Prescription Drug